DataMeds AI and Datavault AI expand healthcare data licensing deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
July 29, 2026 10:16 AM EDTData monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform
Healthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT and MEDS patented technology platforms designed to value, score and monetize healthcare data
TAMPA, FL / ACCESS Newswire / July 29, 2026 / DataMeds AI, Inc. (NASDAQ: MEDS) ("DataMEDS"), a Health IT company leveraging its artificial intelligence platform EinsteinRx and blockchain-enabled smart contacts platform PharmacyChain to provide integrated solutions for the generation,... More



